Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alcidion GroupASX:ALC +1.03% Cash Ratio is 0.64 as of Dec. 2025, which is 23% below its 10-year median of 0.83. The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Alcidion Group ranks better than 52.25% on this metric.
Alcidion Group has a Cash Ratio of 0.64. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Alcidion Group's Cash Ratio or its related term are showing as below:
ASX:ALC'
s Cash Ratio Range Over the Past 10 Years
Min: 0.14 Med: 0.83 Max: 5.59
Current: 0.64
During the past 13 years, Alcidion Group's highest Cash Ratio was 5.59. The lowest was 0.14. And the median was 0.83.
ASX:ALC's Cash Ratio is ranked better than 52.25% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 0.59
vs ASX:ALC: 0.64
Alcidion Group (ASX:ALC) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Alcidion Group Cash Ratio Related Terms
Alcidion Group Cash Ratio Historical Data
* Premium members only.
The historical data trend for Alcidion Group's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Alcidion Group's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcidion Group Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Alcidion Group's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcidion Group (ASX:ALC) has a Cash Ratio of 0.64 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Alcidion Group and its competitors. This is 23% below median its historical median of 0.83. Over the past decade, Alcidion Group's Cash Ratio has ranged from 0.14 to 5.59. According to the industry distribution chart, Alcidion Group ranks #318 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 47.7%.
Is Alcidion Group's Cash Ratio too high?
Alcidion Group's current Cash Ratio of 0.64 is 23% below median its 10-year median of 0.83. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 5.59. The Healthcare Providers & Services industry median Cash Ratio is 0.59. Alcidion Group's value of 0.64 is 8.5% above this industry median. Based on the distribution chart, Alcidion Group ranks #318 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Alcidion Group's Cash Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #318 out of 666 companies for Cash Ratio. This puts Alcidion Group in the upper half of its industry. The industry median Cash Ratio is 0.59. Alcidion Group's value of 0.64 is 8.5% above this benchmark. Historically, Alcidion Group's own Cash Ratio has ranged from 0.14 to 5.59 over the past decade. While the company's 10-year median is 0.83 vs. the industry median of 0.59, Alcidion Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.59, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcidion Group's current Cash Ratio of 0.64 is 8.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current Cash Ratio is 0.64, which is 23% below median its own 10-year median of 0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 18.3% below its estimated fair value. The current Cash Ratio is 0.64, which is 23% below median its 10-year median of 0.83 and 8.5% above the Healthcare Providers & Services industry median of 0.59. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current Cash Ratio is 0.64 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALC has been successfully added to your 
